Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $44.7600 (-0.29%) ($44.7600 - $44.7600) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.42% (three month average) | RSI | 41 | Latest Price | $44.7600(-0.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(64%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -3.21% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-19%) UNG(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.21% (StdDev 6.42%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $37.05(-17.23%) | Resistance Level | $48.31 | 5 Day Moving Average | $45.79(-2.25%) | 10 Day Moving Average | $47.22(-5.21%) | 20 Day Moving Average | $48.31(-7.35%) | To recent high | -18.2% | To recent low | 64.7% | Market Cap | $5.669b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |